Claudia Rubin
Senior Advisor
NHS
Authorities and commissioning bodies shaping financial models and system architecture, including NICE and national commissioners here in the UK
Practical strategies at the intersection of culture, productivity, and system reform
The NHS is the UK’s most significant public service, delivering care at scale while navigating pressures of rising demand, constrained resources, and political scrutiny. Providers and authorities face unique challenges: maintaining productivity post-pandemic, leading cultural transformation in large and complex organisations, and integrating health and social care around patient needs.
Many of these challenges are not structural but behavioural. Leadership culture, professional alignment, and organisational resilience often matter more than formal policy. Hospitals are among the most complex institutions to manage, combining the pace of frontline operations with the accountability of public service. Progress depends on equipping leaders to sustain activity, align incentives, and embed cultures of transparency and continual improvement.
We work with NHS providers and authorities to meet these demands. Our support includes leadership development, culture change, board effectiveness, and coaching programmes, alongside targeted interventions in performance improvement, workforce planning, and digital adoption. We also advise on system-wide challenges, from productivity recovery to hospital discharge pathways and data integration. With experience across trusts, ICSs, and central bodies, we help NHS leaders sharpen priorities, build resilient teams, and deliver change.
Our NHS leads
Our teams combine scientific expertise with deal experience. We bring rigour to forecasting and valuation, assess regulatory and market access dynamics, and help frame development strategies that appeal to potential partners or acquirers. This ensures that investment cases are built on realistic assumptions and that transactions are structured to capture fair value.
Beyond transactions, we support operational priorities such as target operating model design, performance improvement, and digital and data strategy. By combining strategic clarity with an understanding of scientific and clinical realities, we help biotech firms and their backers make sound decisions in an increasingly competitive market.
News & Insights
